LD-2 disclosure · 1st Quarter - Report
ARUP LABORATORIES, INC.
Client
- Name
- ARUP LABORATORIES, INC.
- Description
- Diagnostic testing laboratory
- Location
- Utah · United States of America
Registrant
- Description
- Government Relations Consultant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesBudget/Appropriations
Monitor the following: Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025, Laboratory capacity related issues
LobbyistsJENNIFER LATOURETTE · MATT HENKEN
Health Issues
FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally Prescription drug costs, generally Protecting Access to Medicare Act, Laboratory payment policies Monitor the following: VALID Act, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
LobbyistsMATT HENKEN
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medical/Disease Research/Clinical Labs
FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally Prescription drug costs, generally Protecting Access to Medicare Act, Laboratory payment policies Monitor the following: VALID Act, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues